HUM vs CVS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 21, 2026

HUM

56.9
AI Score
VS
CVS Wins

CVS

67.5
AI Score

Investment Advisor Scores

HUM

57score
Recommendation
HOLD

CVS

68score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HUM CVS Winner
Revenue 39.65B 189.89B CVS
Net Income 1.19B 4.89B CVS
Net Margin 3.0% 2.6% HUM
Operating Income 1.75B 8.95B CVS
ROE 6.4% 7.8% CVS
ROA 2.1% 2.2% CVS
Total Assets 55.28B 220.11B CVS
Cash 4.95B 5.19B CVS
Debt/Equity 0.66 1.10 HUM
Current Ratio 1.77 0.92 HUM
Free Cash Flow 1.13B 8.32B CVS

Relative Price Performance (Last 90 Days)

HUM 1M: -4.0% · 3M: +24.8% CVS 1M: -13.0% · 3M: -0.3%

Current Technical Phase

HUM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.2 · Price: $378.88

CVS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 34

RSI (14): 33.7 · Price: $93.02

Fundamentals Snapshot

Metric HUM CVS
Market Cap
Forward P/E 22.9 10.9
Trailing P/E 35.7 24.7
Revenue (TTM)
Revenue Growth 0.3% 0.1%
Gross Margin 0.1% 0.1%
Operating Margin 0.0% 0.0%
EPS 10.66 3.79
Dividend Yield 0.01% 0.03%

Frequently Asked Questions

Based on our detailed analysis, CVS is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.